Daniela Hofmann

Daniela Hofmann is a Postdoctoral Clinical Scientist at the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel, Switzerland. She has a strong academic background and research focus primarily in the field of infectious diseases and public health.

Educational Background and Research Focus

• Daniela Hofmann holds a PhD and has contributed significantly to studies on the efficacy and safety of treatments for parasitic infections, particularly focusing on helminth infections like hookworm and Strongyloides stercoralis. Her work includes randomized controlled trials assessing new treatment options, such as moxidectin, compared to traditional therapies like ivermectin.12

Professional Contributions

• At Swiss TPH, Hofmann is involved in various clinical research projects aimed at improving public health outcomes in tropical diseases. She has co-authored multiple publications in reputable journals, addressing critical issues related to parasitic infections and their management.34

Notable Publications

• One of her notable publications includes a study on the efficacy of albendazole for treating hookworm infections among different age groups in Côte d'Ivoire, which was published in Clinical Infectious Diseases .1
• Another significant work involves a phase 2b/3 trial comparing moxidectin and ivermectin for treating Strongyloides stercoralis infections, demonstrating moxidectin's non-inferiority to ivermectin .2

Daniela Hofmann's expertise in clinical research and her contributions to understanding treatment efficacy in tropical diseases position her as a valuable asset to public health initiatives at Swiss TPH.